Cipla acquires brand, trademark rights for anti-diabetic drug Vysov in India Press Trust of India Dec 17, 2019 Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus…
Glenmark receives approval to market Remogliflozin and Metformin combination drug EP News Bureau Aug 19, 2019 The company will commercialise the product under the brand names ‘Remo-M’ and Remozen-M’
